封面
市場調查報告書
商品編碼
2147367

中國超音波設備國產化、採購政策及Mindray主導的訂單:全球最具特色的超音波競爭體系專題報告(2024A–2035E)

China Ultrasound Domestic Substitution, Procurement Policy, and the Mindray-Led Order: A Focus Report on the World's Most Distinct Ultrasound Competitive System, 2024A-2035E

出版日期: | 出版商: Marketstrat, Inc. | 英文 32 Pages | 訂單完成後即時交付

價格

報告摘要

這份 Marketstrat® 重點報告將中國診斷超音波市場作為平行競爭系統進行分析。報告基於 Marketstrat 的超音波核心模型和 Markintel®調查方法,涵蓋了2024年至2035年的系統、服務和人工智慧收入,並更新至2026年 7月初的最新資料。

我們認為,中國的商業策略其實就是籌資策略。出貨量的成長速度遠超過硬體銷售,而剩餘市場佔有率的歸屬則取決於公共採購規則。Mindray顯然從由此產生的替代浪潮中獲益匪淺。

主要問題的答案

  • 為什麼出貨量的成長速度超過了系統收入的成長速度,這對成本結構又意味著什麼?
  • 數量採購、2026年續約階段以及「中國製造」標準如何改變競標資格?
  • 國內替代發展到了什麼程度?跨國公司在哪些領域還能維持其地位?
  • 在採購驅動型市場中,人工智慧和業務收益將從何而來?

市場概覽

模型涵蓋五大硬體領域,從高階推車到掌上/POCUS設備,以及服務、核心AI經常性收入和AI價值池橋樑。到2035年,緊湊型攜帶式主機將成為主要收入來源,掌上/POCUS設備將實現最快成長,而高階卡帶則因競標壓力將停滯不前。非硬體收入將低於全球平均。

主要市場趨勢

  • 1.安裝數量成長速度將超過銷售收入成長速度。由於平均單價下降,安裝數量增加帶來的利潤大部分將被抵消,因此將制定基於收入淨額的規模計劃。
  • 2.採購受到規範。引進基於數量的採購制度和錨定價格機制,設備更換將從2026年開始進入更嚴格的分階段週期。
  • 3.本地化是准入的必要條件。隨著國內產品法律標準的建立,中國製造已成為進入官方管道的必要條件。
  • 4.人工智慧的實施將取決於政策條件。人工智慧在基層醫療的應用目標以及按研究付費試點計畫的初步嘗試,推動雲端和遠端審查的經濟可行性。

目錄

執行摘要

關於本報告

第1章 中國的情況:不是區域附錄,而是平行體系

第2章 系統層:可攜式秤佔據主導地位,價值推車停滯不前

  • 依硬體區隔分類的系統銷售額
  • 依硬體區隔分類的出貨台數
  • 依硬體區隔分類的部署台數
  • 解讀成長引擎,搭建成長橋樑

第3章 生態系層與人工智慧橋樑

  • 模擬核心生態系流
  • AI價值池橋樑
  • 政策正積極建構人工智慧的需求方。

第4章 政策與採購架構:市場價格決定規則

  • 數量導向型採購:透過新的安全措施加強紀律
  • 設備更換週期:2025年為高峰期,2026年為收緊期。
  • 國內優先措施:從實踐到成文標準
  • 貿易邊界:與歐盟長達一年的衝突導致了關稅的設立。
  • 法律規範:儘早提高下限並引進上限。

第5章 市場結構展望:資金的分佈與流動

  • 終端市場構成比:由醫院及縣級機構主導,急診護理需求上升
  • 臨床應用構成比:產科及婦科術後再平衡
  • 購買模式構成比:資本驅動,逐步多元化。
  • 營運模式構成比:以收益為準依部門;依管道為分散式。

第6章 競爭動態:Mindray主導的秩序

  • 叢集收益化機制及需要注意的關鍵點
  • 替代記分板
  • 中國在全球市場佔有率結構中的地位
  • 國內供應商關注的關鍵點(摘要)
  • 跨國公司的定位:選擇性防禦與有意本土化
  • 出口方面:國內擴張會帶來全球壓力。

第7章 2026年4月至今的最新進展:過往更新情報

第8章 面臨的挑戰及建議的因應措施

  • 對於跨國OEM廠商
  • 適用於國內供應商及其合作夥伴
  • 對於人工智慧和軟體供應商
  • 針對投資者和企業發展部門

第9章 需要關注的徵兆(未來12-24個月)

  • 調查方法與協調
Product Code: MINTF-02105-UF04

Report Overview

This Marketstrat® Focus Report examines China's diagnostic ultrasound market as a parallel competitive system. Built on Marketstrat's ultrasound core model and the Markintel® methodology, it covers systems, service and AI revenue from 2024 through 2035, with a dated refresh through early July 2026.

In our view, commercial strategy in China is procurement strategy. Shipments expand much faster than hardware revenue, and public procurement rules decide who captures what remains. Mindray is the clearest beneficiary of the resulting substitution wave.

Key Questions Answered

  • Why does shipment growth outpace systems revenue, and what does that mean for cost structure?
  • How are volume-based procurement, the 2026 renewal phase and made-in-China standards changing tender eligibility?
  • How far has domestic substitution moved, and where can multinationals still defend position?
  • Where will AI and service revenue be earned in a procurement-led market?

Market Snapshot

The model covers five hardware segments, from premium carts to handheld/POCUS, plus service, core AI recurring revenue and an AI value-pool bridge. Compact and portable consoles become the revenue center of gravity by 2035 and handheld/POCUS grows fastest, while value carts stall under tender pressure. Above-hardware revenue stays thinner than the global norm.

Key Market Trends

  • 1. Access grows faster than dollars. Falling blended pricing gives back much of the placement gain, so size plans against net revenue.
  • 2. Procurement gains guardrails. Volume-based procurement adds anchor-price mechanisms, and equipment renewal enters a stricter, phased 2026 cycle.
  • 3. Localization becomes the admission ticket. Codified domestic-product standards make made-in-China status a condition of access to the public channel.
  • 4. AI is bought on policy's terms. Primary-care AI goals and early per-study reimbursement pilots favor cloud and remote-review economics.

Competitive Structure

The report analyzes a Mindray-led order across four linked layers: domestic OEM scale, local AI and software, component sovereignty, and exports. It tracks domestic gains in public-tender value, profiles Mindray, SonoScape, United Imaging Healthcare and smaller local players, and reviews how GE HealthCare, Philips and other multinationals are localizing or narrowing focus.

What's Inside

Systems and ecosystem layers: Revenue, shipments and installed base by hardware segment, the systems growth bridge and the AI value-pool bridge.

Policy architecture: Procurement, renewal, domestic preference, trade measures and NMPA regulation, with a 2024–2026 timeline.

Market structure views: End-market, clinical application, purchase model and operating model mixes.

Refresh and actions: A dated freshness log, recommendations by participant type and 12–24-month signals.

Who Should Read This Report

  • Investors underwriting China medtech exposure
  • Multinational strategy teams weighing localization
  • Domestic ultrasound vendors and component suppliers
  • AI developers targeting county and primary-care deployment
  • Export planners assessing China-rooted competition in third markets

Why This Report

The report treats China as a strategic theater of its own rather than a regional footnote, ties every baseline to Marketstrat's ultrasound core model, and logs later developments separately so readers see what changed.

Table of Contents

EXECUTIVE SUMMARY

ABOUT THIS REPORT

1. THE CHINA READ: A PARALLEL SYSTEM, NOT A REGIONAL FOOTNOTE

2. THE SYSTEMS LAYER: PORTABLE SCALE WINS, VALUE CARTS STALL

  • 2.1 SYSTEMS REVENUE BY HARDWARE SEGMENT
  • 2.2 UNIT SHIPMENTS BY HARDWARE SEGMENT
  • 2.3 INSTALLED BASE BY HARDWARE SEGMENT
  • 2.4 THE GROWTH-ENGINE READ AND THE GROWTH BRIDGE

3. THE ECOSYSTEM LAYER AND THE AI BRIDGE

  • 3.1 MODELED CORE ECOSYSTEM STREAMS
  • 3.2 THE AI VALUE-POOL BRIDGE
  • 3.3 POLICY IS ACTIVELY BUILDING THE AI DEMAND SIDE

4. POLICY AND PROCUREMENT ARCHITECTURE: THE RULES THAT PRICE THE MARKET

  • 4.1 VOLUME-BASED PROCUREMENT: DISCIPLINE WITH NEW GUARDRAILS
  • 4.2 THE EQUIPMENT-RENEWAL CYCLE: 2025'S SURGE, 2026'S STRICTER PHASE
  • 4.3 DOMESTIC PREFERENCE: FROM PRACTICE TO CODIFIED STANDARD
  • 4.4 THE TRADE BOUNDARY: EU STANDOFF AT ONE YEAR, TARIFFS EMBEDDED
  • 4.5 THE REGULATORY LAYER: HIGHER FLOOR, FASTER CEILING

5. MARKET STRUCTURE VIEWS: WHERE THE MONEY SITS AND WHERE IT MOVES

  • 5.1 END-MARKET MIX: HOSPITAL- AND COUNTY-LED, ACUTE-CARE RISING
  • 5.2 CLINICAL APPLICATION MIX: THE POST-OB REBALANCING
  • 5.3 PURCHASE MODEL MIX: CAPITAL-LED, SLOWLY DIVERSIFYING
  • 5.4 OPERATING MODEL MIX: DEPARTMENT-BASED BY REVENUE, DISTRIBUTED BY VECTOR

6. COMPETITIVE DYNAMICS: THE MINDRAY-LED ORDER

  • 6.1 HOW THE CLUSTER MONETIZES, AND WHAT TO WATCH
  • 6.2 THE SUBSTITUTION SCOREBOARD
  • 6.3 WHERE CHINA SITS IN THE GLOBAL SHARE STRUCTURE
  • 6.4 DOMESTIC VENDOR SPOTLIGHTS (CONDENSED)
  • 6.5 MULTINATIONAL POSITIONING: DEFEND SELECTIVELY, LOCALIZE DELIBERATELY
  • 6.6 THE EXPORT DIMENSION: DOMESTIC SCALE BECOMES GLOBAL PRESSURE

7. WHAT'S NEW SINCE APRIL 2026: THE DATED REFRESH

8. IMPLICATIONS AND RECOMMENDED ACTIONS

  • 8.1 FOR MULTINATIONAL OEMS
  • 8.2 FOR DOMESTIC VENDORS AND THEIR PARTNERS
  • 8.3 FOR AI AND SOFTWARE VENDORS
  • 8.4 FOR INVESTORS AND CORPORATE DEVELOPMENT

9. SIGNALS TO WATCH (NEXT 12–24 MONTHS)

  • METHODOLOGY AND RECONCILIATION

List of Tables

  • TABLE 1: CHINA: ULTRASOUND MARKET SNAPSHOT (2024A, 2030E, 2035E, CAGR)
  • TABLE 2: CHINA: ULTRASOUND SYSTEMS REVENUE BY HARDWARE SEGMENT ($M; 2024A, 2030E, 2035E)
  • TABLE 3: CHINA: ULTRASOUND UNIT SHIPMENTS BY HARDWARE SEGMENT (UNITS; 2024A, 2030E, 2035E)
  • TABLE 4: CHINA: ULTRASOUND INSTALLED BASE BY HARDWARE SEGMENT (UNITS; 2024A, 2030E, 2035E)
  • TABLE 5: CHINA: ULTRASOUND ECOSYSTEM REVENUE ($M; 2024A, 2030E, 2035E, CAGR)
  • TABLE 6: CHINA: ULTRASOUND AI VALUE-POOL BRIDGE REVENUE ($M; 2024A, 2030E, 2035E, CAGR)
  • TABLE 7: CHINA: ECOSYSTEM REVENUE BY END-MARKET MIX ($M; 2024A, 2030E, 2035E, CAGR)
  • TABLE 8: CHINA: ECOSYSTEM REVENUE BY CLINICAL APPLICATION MIX ($M; 2024A, 2030E, 2035E, CAGR)
  • TABLE 9: CHINA: SYSTEMS REVENUE BY PURCHASE MODEL MIX ($M; 2024A, 2030E, 2035E, CAGR)
  • TABLE 10: CHINA: ECOSYSTEM REVENUE BY OPERATING MODEL MIX ($M; 2024A, 2030E, 2035E, CAGR)
  • TABLE 11: GLOBAL ULTRASOUND SYSTEMS OEM SHARE BANDS (2024A, GLOBAL; DIRECTIONAL): CHINA-RELEVANT ROWS IN CONTEXT
  • TABLE 12: CHINA ULTRASOUND: FRESHNESS LOG (APRIL–EARLY JULY 2026, PLUS LOAD-BEARING PRIOR ITEMS)

List of Figures

  • FIGURE 1: CHINA: ULTRASOUND SYSTEMS GROWTH BRIDGE, 2024A–2035E
  • FIGURE 2: CHINA ULTRASOUND POLICY TIMELINE, 2024–2026
  • FIGURE 3: CHINA ULTRASOUND ECOSYSTEM MAP: ROLE STRUCTURE, NOT SHARE CLAIM
  • FIGURE 4: CHINA ULTRASOUND: DOMESTIC VS. MULTINATIONAL TENDER-VALUE SHARE SHIFT (DIRECTIONAL BANDS)